Cargando…
Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Higher Education Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881410/ https://www.ncbi.nlm.nih.gov/pubmed/31187422 http://dx.doi.org/10.1007/s13238-019-0640-1 |
| _version_ | 1783473943026335744 |
|---|---|
| author | Ge, Yuanlong Wu, Shu Zhang, Zepeng Li, Xiaocui Li, Feng Yan, Siyu Liu, Haiying Huang, Junjiu Zhao, Yong |
| author_facet | Ge, Yuanlong Wu, Shu Zhang, Zepeng Li, Xiaocui Li, Feng Yan, Siyu Liu, Haiying Huang, Junjiu Zhao, Yong |
| author_sort | Ge, Yuanlong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6881410 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Higher Education Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68814102019-12-10 Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers Ge, Yuanlong Wu, Shu Zhang, Zepeng Li, Xiaocui Li, Feng Yan, Siyu Liu, Haiying Huang, Junjiu Zhao, Yong Protein Cell Correction Higher Education Press 2019-06-12 2019-12 /pmc/articles/PMC6881410/ /pubmed/31187422 http://dx.doi.org/10.1007/s13238-019-0640-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Ge, Yuanlong Wu, Shu Zhang, Zepeng Li, Xiaocui Li, Feng Yan, Siyu Liu, Haiying Huang, Junjiu Zhao, Yong Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers |
| title | Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers |
| title_full | Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers |
| title_fullStr | Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers |
| title_full_unstemmed | Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers |
| title_short | Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers |
| title_sort | correction to: inhibition of p53 and/or akt as a new therapeutic approach specifically targeting alt cancers |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881410/ https://www.ncbi.nlm.nih.gov/pubmed/31187422 http://dx.doi.org/10.1007/s13238-019-0640-1 |
| work_keys_str_mv | AT geyuanlong correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers AT wushu correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers AT zhangzepeng correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers AT lixiaocui correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers AT lifeng correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers AT yansiyu correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers AT liuhaiying correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers AT huangjunjiu correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers AT zhaoyong correctiontoinhibitionofp53andoraktasanewtherapeuticapproachspecificallytargetingaltcancers |